{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:05:03Z","timestamp":1777633503882,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,28]]},"DOI":"10.7759\/cureus.107926","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:40:11Z","timestamp":1777437611000},"source":"Crossref","is-referenced-by-count":0,"title":["Expert Opinion on Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell (BMMSC) Therapy for Knee Osteoarthritis: Clinical Insights, Efficacy, and Safety"],"prefix":"10.7759","author":[{"given":"Sanjay B","family":"Londhe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Goni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Sauhta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pardeep","family":"Bageja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natesh","family":"Kolusu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijal","family":"Modi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bishal","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajashekar","family":"Danda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girish","family":"Bhalerao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Shriram Dhanasekaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Palkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sucheta","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Osteoarthritis. (2023). Accessed. December 5, 2025: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/osteoarthritis\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2023.101855","article-title":"Clinical aspects and outcomes in osteoarthritis","volume":"37","author":"Tuncay Duru\u00f6z M","year":"2023","unstructured":"Tuncay Duru\u00f6z M, \u00d6z N, G\u00fcrsoy DE, Hande Gezer H. Clinical aspects and outcomes in osteoarthritis. Best Pract Res Clin Rheumatol. 2023, 37:101855. 10.1016\/j.berh.2023.101855","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref3","article-title":"Knee osteoarthritis prevalence, risk factors, pathogenesis and features: part I","volume":"2","author":"Heidari B","year":"2011","unstructured":"Heidari B. Knee osteoarthritis prevalence, risk factors, pathogenesis and features: part I. Caspian J Intern Med. 2011, 2:205-12.","journal-title":"Caspian J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2023.12180","article-title":"Knee osteoarthritis: current status and research progress in treatment (review)","volume":"26","author":"Geng R","year":"2023","unstructured":"Geng R, Li J, Yu C, et al.. Knee osteoarthritis: current status and research progress in treatment (review). Exp Ther Med. 2023, 26:481. 10.3892\/etm.2023.12180","journal-title":"Exp Ther Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.06.68","article-title":"Non-operative treatment options for knee osteoarthritis","volume":"7","author":"DeRogatis M","year":"2019","unstructured":"DeRogatis M, Anis HK, Sodhi N, et al.. Non-operative treatment options for knee osteoarthritis. Ann Transl Med. 2019, 7:S245. 10.21037\/atm.2019.06.68","journal-title":"Ann Transl Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000041335","article-title":"Recent advances in osteoarthritis research: a review of treatment strategies, mechanistic insights, and acupuncture","volume":"104","author":"Lou Z","year":"2025","unstructured":"Lou Z, Bu F. Recent advances in osteoarthritis research: a review of treatment strategies, mechanistic insights, and acupuncture. Medicine (Baltimore). 2025, 104:e41335. 10.1097\/MD.0000000000041335","journal-title":"Medicine (Baltimore)"},{"key":"ref7","article-title":"Mesenchymal stem cells in osteoarthritis therapy: a review","volume":"13","author":"Zhu C","year":"2021","unstructured":"Zhu C, Wu W, Qu X. Mesenchymal stem cells in osteoarthritis therapy: a review. Am J Transl Res. 2021, 13:448-61.","journal-title":"Am J Transl Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jot.2020.03.015","article-title":"Mesenchymal stem cells\u00a0in knee osteoarthritis treatment: a systematic review and meta-analysis","volume":"24","author":"Song Y","year":"2020","unstructured":"Song Y, Zhang J, Xu H, et al.. Mesenchymal stem cells\u00a0in knee osteoarthritis treatment: a systematic review and meta-analysis. J Orthop Translat. 2020, 24:121-30. 10.1016\/j.jot.2020.03.015","journal-title":"J Orthop Translat"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee","volume":"29","author":"Altman R","year":"1986","unstructured":"Altman R, Asch E, Bloch D, et al.. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum. 1986, 29:1039-49. 10.1002\/art.1780290816","journal-title":"Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.051482","article-title":"Clinical classification criteria for knee osteoarthritis: performance in the general population and primary care","volume":"65","author":"Peat G","year":"2006","unstructured":"Peat G, Thomas E, Duncan R, Wood L, Hay E, Croft P. Clinical classification criteria for knee osteoarthritis: performance in the general population and primary care. Ann Rheum Dis. 2006, 65:1363-7. 10.1136\/ard.2006.051482","journal-title":"Ann Rheum Dis"},{"key":"ref11","article-title":"Knee osteoarthritis diagnosis, treatment and associated factors of progression: part II","volume":"2","author":"Heidari B","year":"2011","unstructured":"Heidari B. Knee osteoarthritis diagnosis, treatment and associated factors of progression: part II. Caspian J Intern Med. 2011, 2:249-55.","journal-title":"Caspian J Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7542.639","article-title":"Osteoarthritis","volume":"332","author":"Hunter DJ","year":"2006","unstructured":"Hunter DJ, Felson DT. Osteoarthritis. BMJ. 2006, 332:639-42. 10.1136\/bmj.332.7542.639","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2007.12.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines","volume":"16","author":"Zhang W","year":"2008","unstructured":"Zhang W, Moskowitz RW, Nuki G, et al.. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008, 16:137-62. 10.1016\/j.joca.2007.12.013","journal-title":"Osteoarthritis Cartilage"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2012.10.003","article-title":"Imaging of osteoarthritis","volume":"39","author":"Guermazi A","year":"2013","unstructured":"Guermazi A, Hayashi D, Eckstein F, Hunter DJ, Duryea J, Roemer FW. Imaging of osteoarthritis. Rheum Dis Clin North Am. 2013, 39:67-105. 10.1016\/j.rdc.2012.10.003","journal-title":"Rheum Dis Clin North Am"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2005.08.003","article-title":"Is MRI useful in osteoarthritis?","volume":"20","author":"Conaghan P","year":"2006","unstructured":"Conaghan P. Is MRI useful in osteoarthritis?. Best Pract Res Clin Rheumatol. 2006, 20:57-68. 10.1016\/j.berh.2005.08.003","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/ard.16.4.494","article-title":"Radiological assessment of osteo-arthrosis","volume":"16","author":"Kellgren JH","year":"1957","unstructured":"Kellgren JH, Lawrence J. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957, 16:494-502. 10.1136\/ard.16.4.494","journal-title":"Ann Rheum Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.113100","article-title":"EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis","volume":"69","author":"Zhang W","year":"2010","unstructured":"Zhang W, Doherty M, Peat G, et al.. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis. 2010, 69:483-9. 10.1136\/ard.2009.113100","journal-title":"Ann Rheum Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11112894","article-title":"StemOne(TM)\/Stempeucel(\u00ae): CDSCO approved, adult human bone marrow-derived, cultured, pooled, allogenic mesenchymal stem cells for knee osteoarthritis","volume":"11","author":"Gupta A","year":"2023","unstructured":"Gupta A. StemOne(TM)\/Stempeucel(\u00ae): CDSCO approved, adult human bone marrow-derived, cultured, pooled, allogenic mesenchymal stem cells for knee osteoarthritis. Biomedicines. 2023, 11:10.3390\/biomedicines11112894","journal-title":"Biomedicines"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/03635465231180323","article-title":"Efficacy and safety of Stempeucel in osteoarthritis of the knee: a Phase 3 randomized, double-blind, multicenter, placebo-controlled study","volume":"51","author":"Gupta PK","year":"2023","unstructured":"Gupta PK, Maheshwari S, Cherian JJ, et al.. Efficacy and safety of Stempeucel in osteoarthritis of the knee: a Phase 3 randomized, double-blind, multicenter, placebo-controlled study. Am J Sports Med. 2023, 51:2254-66. 10.1177\/03635465231180323","journal-title":"Am J Sports Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ocarto.2025.100723","article-title":"Two-year efficacy and safety outcomes of using allogeneic, pooled mesenchymal stromal cells for osteoarthritis of the knee in a double-blind randomized placebo-controlled phase 3 study","volume":"8(1)","author":"Gupta PK","year":"2025","unstructured":"Gupta PK, Maheshwari S, Cherian JJ, et al.. Two-year efficacy and safety outcomes of using allogeneic, pooled mesenchymal stromal cells for osteoarthritis of the knee in a double-blind randomized placebo-controlled phase 3 study. Osteoarthr Cartil Open. 2025, 8(1):100723. 10.1016\/j.ocarto.2025.100723","journal-title":"Osteoarthr Cartil Open"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-025-04252-2","article-title":"Efficacy and safety of mesenchymal stem cells in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Cao M","year":"2025","unstructured":"Cao M, Ou Z, Sheng R, et al.. Efficacy and safety of mesenchymal stem cells in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Stem Cell Res Ther. 2025, 16:122. 10.1186\/s13287-025-04252-2","journal-title":"Stem Cell Res Ther"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/2041731420943839","article-title":"Mesenchymal stem cells for cartilage regeneration","volume":"11","author":"Le H","year":"2020","unstructured":"Le H, Xu W, Zhuang X, Chang F, Wang Y, Ding J. Mesenchymal stem cells for cartilage regeneration. J Tissue Eng. 2020, 11:10.1177\/2041731420943839","journal-title":"J Tissue Eng"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000678","article-title":"Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial","volume":"99","author":"Vega A","year":"2015","unstructured":"Vega A, Mart\u00edn-Ferrero MA, Del Canto F, et al.. Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial. Transplantation. 2015, 99:1681-90. 10.1097\/TP.0000000000000678","journal-title":"Transplantation"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1411507","article-title":"Immunoregulatory paracrine effect of mesenchymal stem cells and mechanism in the treatment of osteoarthritis","volume":"12","author":"Zhang X","year":"2024","unstructured":"Zhang X, Liu T, Ran C, et al.. Immunoregulatory paracrine effect of mesenchymal stem cells and mechanism in the treatment of osteoarthritis. Front Cell Dev Biol. 2024, 12:1411507. 10.3389\/fcell.2024.1411507","journal-title":"Front Cell Dev Biol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1195-7","article-title":"Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel\u00ae): preclinical and clinical trial in osteoarthritis of the knee joint","volume":"18","author":"Gupta PK","year":"2016","unstructured":"Gupta PK, Chullikana A, Rengasamy M, et al.. Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel\u00ae): preclinical and clinical trial in osteoarthritis of the knee joint. Arthritis Res Ther. 2016, 18:301. 10.1186\/s13075-016-1195-7","journal-title":"Arthritis Res Ther"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcot.2022.101804","article-title":"The promising role of autologous and allogeneic mesenchymal stromal cells in managing knee osteoarthritis. What is beyond Mesenchymal stromal cells?","volume":"26","author":"Pandey V","year":"2022","unstructured":"Pandey V, Madi S, Gupta P. The promising role of autologous and allogeneic mesenchymal stromal cells in managing knee osteoarthritis. What is beyond Mesenchymal stromal cells?. J Clin Orthop Trauma. 2022, 26:101804. 10.1016\/j.jcot.2022.101804","journal-title":"J Clin Orthop Trauma"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-73299-8_34","article-title":"Allogeneic bone marrow MSC therapy for knee osteoarthritis","author":"Weiss JN","year":"2021","unstructured":"Weiss JN. Allogeneic bone marrow MSC therapy for knee osteoarthritis. Orthopedic Stem Cell Surgery. Springer, Cham, Switzerland; 2021. 183-6. 10.1007\/978-3-030-73299-8_34"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24129939","article-title":"Clinical trials with mesenchymal stem cell therapies for osteoarthritis: challenges in the regeneration of articular cartilage","volume":"24","author":"Carneiro DC","year":"2023","unstructured":"Carneiro DC, Ara\u00fajo LT, Santos GC, et al.. Clinical trials with mesenchymal stem cell therapies for osteoarthritis: challenges in the regeneration of articular cartilage. Int J Mol Sci. 2023, 24:10.3390\/ijms24129939","journal-title":"Int J Mol Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ocarto.2024.100500","article-title":"Safety and efficacy of an allogeneic adipose-derived mesenchymal stem cell preparation in the treatment of knee osteoarthritis: a Phase I\/IIa randomised controlled trial","volume":"6","author":"Freitag J","year":"2024","unstructured":"Freitag J, Chamberlain M, Wickham J, et al.. Safety and efficacy of an allogeneic adipose-derived mesenchymal stem cell preparation in the treatment of knee osteoarthritis: a Phase I\/IIa randomised controlled trial. Osteoarthr Cartil Open. 2024, 6:100500. 10.1016\/j.ocarto.2024.100500","journal-title":"Osteoarthr Cartil Open"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/ph16091334","article-title":"Mesenchymal stem cell therapies approved by regulatory agencies around the world","volume":"16","author":"Fern\u00e1ndez-Garza LE","year":"2023","unstructured":"Fern\u00e1ndez-Garza LE, Barrera-Barrera SA, Barrera-Salda\u00f1a HA. Mesenchymal stem cell therapies approved by regulatory agencies around the world. Pharmaceuticals (Basel). 2023, 16:10.3390\/ph16091334","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12196311","article-title":"Mesenchymal stem cell therapy in multiple sclerosis: a systematic review and meta-analysis","volume":"12","author":"Islam MA","year":"2023","unstructured":"Islam MA, Alam SS, Kundu S, et al.. Mesenchymal stem cell therapy in multiple sclerosis: a systematic review and meta-analysis. J Clin Med. 2023, 12:10.3390\/jcm12196311","journal-title":"J Clin Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.5312\/wjo.v13.i3.212","article-title":"Conservative treatment of knee osteoarthritis: a review of the literature","volume":"13","author":"Lim WB","year":"2022","unstructured":"Lim WB, Al-Dadah O. Conservative treatment of knee osteoarthritis: a review of the literature. World J Orthop. 2022, 13:212-29. 10.5312\/wjo.v13.i3.212","journal-title":"World J Orthop"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.50510","article-title":"A comprehensive review of treatment strategies for early avascular necrosis","volume":"15","author":"Lohiya A Jr","year":"2023","unstructured":"Lohiya A Jr, Dhaniwala N, Dudhekar U, Goyal S, Patel SK. A comprehensive review of treatment strategies for early avascular necrosis. Cureus. 2023, 15:e50510. 10.7759\/cureus.50510","journal-title":"Cureus"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2019.06.011","article-title":"OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis","volume":"27","author":"Bannuru RR","year":"2019","unstructured":"Bannuru RR, Osani MC, Vaysbrot EE, et al.. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019, 27:1578-89. 10.1016\/j.joca.2019.06.011","journal-title":"Osteoarthritis Cartilage"},{"key":"ref35","unstructured":"ESSKA ORBIT consensus. The use of injectable orthobiologics for knee osteoarthritis, part 2. cell-based therapy (CBT) - summary report. (2024). Accessed: December 23, 2025: https:\/\/cdn.ymaws.com\/www.esska.org\/resource\/resmgr\/docs\/consensus_projects\/2024_orbit_summary.pdf."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/459155-expert-opinion-on-allogeneic-bone-marrow-derived-mesenchymal-stem-cell-bmmsc-therapy-for-knee-osteoarthritis-clinical-insights-efficacy-and-safety","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:40:30Z","timestamp":1777437630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/459155-expert-opinion-on-allogeneic-bone-marrow-derived-mesenchymal-stem-cell-bmmsc-therapy-for-knee-osteoarthritis-clinical-insights-efficacy-and-safety"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.107926","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,28]]}}}